Company Profile

N&N Scientific Inc
Profile last edited on: 12/24/2014            CAGE: 4LTW9

antiviral drug against the Herpes and Orthopox virus families
Year Founded
1st Award Year
Latest Award
Program Status
Popularity Index


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10521 Alloway Drive
Potomac, MD 20854
   (301) 983-4006
Multiple Locations:   
Congressional District:   06
County:   Montgomery

Public Profile

N&N Scientific, Inc. (N&N) is a pharmaceutical company whose first new product candidate is N-MethanoCarbaThymidine (N-MCT), a promising antiviral drug that has shown potent and selective activity against the Herpes and Orthopox virus families. N&N proposes to develop N-MCT as a therapeutic against the Herpesviridae, Papillomaviridae and Poxviridae genera of Class I dsDNA viruses, including HSV-1, HSV-2, HSV-8, VZV, EBV, smallpox, Vaccinia, cowpox, and HPV.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2014 2 NIH $3,479,710
N-Methanocarbathymidine (N-Mct) for the Treatment of Herpes and Pox Virus Infecti

Key People / Management

  Aquilur Rahman

SBIR firms in the news

There are no news available.